
Professor Rachel Crowley
Principal Investigator
School of Medicine
The RD-PREM Project is a collaborative initiative led by three core research partners:
Funded by the Health Research Board (HRB) under the Rare Disease Catalyst Award (Grant No. R26672), this project aims to design, develop, and validate patient-reported experience measures (PREMs) that are specifically tailored to the needs of individuals living with rare diseases.
These tools will capture real, meaningful insights into patient experiences with healthcare, supporting more person-centred services, better care delivery, and more informed policy in the rare disease space.
Rare diseases pose unique challenges:
Despite progress through the European Reference Networks (ERNs)—collaborative hubs for rare disease care involving over 300 hospitals—there remains no validated PREM framework that can be used across all rare diseases.
RD-PREM fills this gap, enabling healthcare systems to:
We aim to develop validated, accessible RD-PREM questionnaires that:
The project employs a participatory, multiple-method, and multi-phase approach. This ensures diverse and continuous involvement from:
To maximise reach and inclusion, we use both in-person and online engagement, leveraging EURORDIS’ established platforms for survey distribution and expert recruitment.
The RD-PREM Project is made possible by the Health Research Board and the passionate efforts of our research partners, clinical collaborators, patient advocates, and—most importantly—individuals living with rare diseases who share their stories and insights to shape a better future for all.
Pilot H-CARE Survey confirms lack of PREMs for rare diseases (2019–2020)
Scoping literature review completed (2022–2024)
Expert consultations and focus groups to design the first RD-PREM draft (2025)
Testing & validation across five Irish hospital sites (2026)
Finalise, publish and disseminate validated RD-PREM tools (2027)
The Rare Disease Research Catalyst Consortium (RDCat) brings together healthcare professionals, researchers, and patient advocates across Ireland. Hosted by UCD and supported by institutions including:
Key partners include Rare Diseases Ireland and EURORDIS – Rare Diseases Europe. The Consortium is dedicated to advancing rare disease research and driving policy change through coordinated and collaborative action.
School of Medicine
University College Dublin
Rare Diseases Ireland
Rare Diseases Ireland
EURORDIS